Efficacy of Bacillus clausii as an adjuvant therapy in pathological neonatal unconjugated hyperbilirubinemia in the Nile Delta region of Egypt: a randomized controlled trial.
- 2026-06-11
- RCT · n = 22
- Journal of tropical pediatrics 72(4)
- Samah S M Hussein
- Sahar M El-Haggar
- Sahar K Hegazy
- Mohamed A Rowisha
- PubMed: 42378553
- DOI: 10.1093/tropej/fmag047
- High evidence
- Clinical
By the end of treatment, the probiotic group showed a significantly greater reduction in lipopolysaccharide and tumor necrosis factor-α levels compared with the control group.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes